1993
DOI: 10.1016/0003-4975(93)90485-z
|View full text |Cite
|
Sign up to set email alerts
|

Bovine internal mammary artery as a conduit for coronary revascularization: Long-term results

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
10
0
1

Year Published

1994
1994
2023
2023

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 32 publications
(11 citation statements)
references
References 8 publications
0
10
0
1
Order By: Relevance
“…Only one long-term follow-up clinical report was available, and it revealed graft patency rates of 16% (3/19) at 3-23 months [24]. This is much lower than the reported patency rates for PTFE grafts.…”
Section: Biologic Prosthesismentioning
confidence: 88%
See 1 more Smart Citation
“…Only one long-term follow-up clinical report was available, and it revealed graft patency rates of 16% (3/19) at 3-23 months [24]. This is much lower than the reported patency rates for PTFE grafts.…”
Section: Biologic Prosthesismentioning
confidence: 88%
“…The No-React bovine internal mammary artery 7 57 5 Laube et al [40] 2000 Endothelial cell-seeded PTFE graft 14 90.5 27.7 months Mitchell et al [24] 1993 Bovine internal mammary artery 18 16 2 Laub et al [51] 1992 Cryopreserved veins 19 41 <1 Suma et al [23] 1991 Bovine internal thoracic artery 2 100 20 days and 10 days attempts using polyurethane led to high rates of aneurysm formation and thrombosis compared with conventional prosthetic grafts [28]. However, there has been renewed interest in using modified forms of polyurethane grafts that are biostable [29], and retain seeded ECs [30].…”
Section: Synthetic Biomaterials and Polyurethanesmentioning
confidence: 99%
“…Many smallcaliber vascular grafts for use as CABG conduits have been developed in the past, but most of them have failed. 6,7 Experimental data with low-flow biologic grafts in the aortocoronary position suggest that all types of these grafts are prone to early occlusion. 8,9 The use of BIMA was first reported in 1989 by Suma and colleagues 2 who showed that 4 of 5 BIMA grafts were patent at 2 months.…”
Section: Discussionmentioning
confidence: 99%
“…после операции, из которых только 3 (15,8%) телячьих ВГА были проходимы в сравнении с проходимостью в 85,7% собственных ЛВГА и 75% аутовен из БПВ. Все пациенты находились на антиагрегантной и/или антикоагуляционной терапии [25].…”
Section: биологические сосудистые протезыunclassified